CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
0.1864
1.63%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.0009
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Cue Health Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 0.1839
Open* 0.1934
1-Year Change* -89.2%
Day's Range* 0.1849 - 0.1944
52 wk Range 0.16-2.82
Average Volume (10 days) 676.85K
Average Volume (3 months) 21.25M
Market Cap 31.24M
P/E Ratio -100.00K
Shares Outstanding 154.63M
Revenue 198.92M
EPS -1.69
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Mar 13, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 27, 2024 0.1839 -0.0060 -3.16% 0.1899 0.1899 0.1829
Mar 26, 2024 0.1859 -0.0051 -2.67% 0.1910 0.1910 0.1799
Mar 25, 2024 0.1795 -0.0113 -5.92% 0.1908 0.1908 0.1789
Mar 22, 2024 0.1817 -0.0042 -2.26% 0.1859 0.1919 0.1817
Mar 21, 2024 0.1846 -0.0003 -0.16% 0.1849 0.1897 0.1802
Mar 20, 2024 0.1802 -0.0167 -8.48% 0.1969 0.1978 0.1789
Mar 19, 2024 0.1911 -0.0188 -8.96% 0.2099 0.2099 0.1909
Mar 18, 2024 0.1968 -0.0131 -6.24% 0.2099 0.2154 0.1899
Mar 15, 2024 0.2088 -0.0232 -10.00% 0.2320 0.2320 0.1998
Mar 14, 2024 0.2149 -0.0550 -20.38% 0.2699 0.2700 0.2129
Mar 13, 2024 0.2754 0.0153 5.88% 0.2601 0.2985 0.2601
Mar 12, 2024 0.2632 -0.0167 -5.97% 0.2799 0.2800 0.2599
Mar 11, 2024 0.2763 0.0164 6.31% 0.2599 0.2799 0.2598
Mar 8, 2024 0.2578 0.0068 2.71% 0.2510 0.2671 0.2457
Mar 7, 2024 0.2517 0.0018 0.72% 0.2499 0.2527 0.2423
Mar 6, 2024 0.2426 0.0086 3.68% 0.2340 0.2566 0.2340
Mar 5, 2024 0.2399 -0.0100 -4.00% 0.2499 0.2499 0.2307
Mar 4, 2024 0.2491 -0.0156 -5.89% 0.2647 0.2699 0.2449
Mar 1, 2024 0.2649 -0.0150 -5.36% 0.2799 0.2799 0.2548
Feb 29, 2024 0.3199 0.0510 18.97% 0.2689 0.3455 0.2499

Cue Health Inc. Events

Time (UTC) Country Event
Wednesday, May 8, 2024

Time (UTC)

10:59

Country

US

Event

Q1 2024 Cue Health Inc Earnings Release
Q1 2024 Cue Health Inc Earnings Release

Forecast

-

Previous

-
Tuesday, June 4, 2024

Time (UTC)

16:00

Country

US

Event

Cue Health Inc Annual Shareholders Meeting
Cue Health Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019
Total revenue 483.476 618.107 22.953 6.626
Revenue 483.476 618.107 22.953 6.626
Cost of Revenue, Total 329.973 276.542 14.951 0
Gross Profit 153.503 341.565 8.002 6.626
Total Operating Expense 689.128 429.886 68.689 27.393
Selling/General/Admin. Expenses, Total 185.683 108.517 24.65 5.988
Research & Development 171.452 42.829 28.478 21.405
Operating Income -205.652 188.221 -45.736 -20.767
Interest Income (Expense), Net Non-Operating -0.645 -69.369 -0.374 -0.152
Other, Net 2.493 0.325 -1.242 0.313
Net Income Before Taxes -203.804 119.177 -47.352 -20.606
Net Income After Taxes -194.056 86.418 -47.352 -20.606
Net Income Before Extra. Items -194.056 86.418 -47.352 -20.606
Net Income -194.056 86.418 -47.352 -20.606
Income Available to Common Excl. Extra. Items -194.056 86.418 -47.352 -20.606
Income Available to Common Incl. Extra. Items -194.056 86.418 -47.352 -20.606
Diluted Net Income -194.056 86.418 -47.352 -20.606
Diluted Weighted Average Shares 148.025 146.629 143.767 143.767
Diluted EPS Excluding Extraordinary Items -1.31097 0.58936 -0.32937 -0.14333
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -1.3021 0.59925 -0.32512 -0.14333
Unusual Expense (Income) 2.02 1.998 0.61
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 9.896 24.765 146.777 69.589 87.7
Revenue 9.896 24.765 146.777 69.589 87.7
Cost of Revenue, Total 29.346 39.823 90.783 50.595 101.898
Gross Profit -19.45 -15.058 55.994 18.994 -14.198
Total Operating Expense 95.289 120.615 185.401 137.002 190.163
Selling/General/Admin. Expenses, Total 22.762 28.186 38.469 43.754 42.382
Research & Development 36.536 44.733 56.149 42.516 44
Unusual Expense (Income) 6.645 7.873 0 0.137 1.883
Operating Income -85.393 -95.85 -38.624 -67.413 -102.463
Interest Income (Expense), Net Non-Operating -0.291 -0.22 -0.232 -0.346 -0.016
Other, Net 1.82 1.872 2.035 0.409 0.043
Net Income Before Taxes -83.864 -94.198 -36.821 -67.35 -102.436
Net Income After Taxes -83.864 -94.198 -31.506 -66.303 -99.05
Net Income Before Extra. Items -83.864 -94.198 -31.506 -66.303 -99.05
Net Income -83.864 -94.198 -31.506 -66.303 -99.05
Income Available to Common Excl. Extra. Items -83.864 -94.198 -31.506 -66.303 -99.05
Income Available to Common Incl. Extra. Items -83.864 -94.198 -31.506 -66.303 -99.05
Diluted Net Income -83.864 -94.198 -31.506 -66.303 -99.05
Diluted Weighted Average Shares 151.869 151.084 149.769 148.286 147.498
Diluted EPS Excluding Extraordinary Items -0.55221 -0.62348 -0.21036 -0.44713 -0.67153
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.50846 -0.57137 -0.21036 -0.44653 -0.66324
  • Annual
  • Quarterly
2022 2021 2020 2019
Total Current Assets 371.153 670.022 183.698 15.504
Cash and Short Term Investments 241.53 409.873 121.578 14.328
Cash & Equivalents 241.53 409.873 121.578 14.328
Total Receivables, Net 18.751 104.589 4.168 0.2
Accounts Receivable - Trade, Net 18.751 104.589 4.168 0.2
Total Inventory 82.21 88.388 36.842 0
Prepaid Expenses 15.728 45.889 13.847 0.669
Other Current Assets, Total 12.934 21.283 7.263 0.307
Total Assets 694.58 940.06 316.328 27.361
Property/Plant/Equipment, Total - Net 274.596 256.93 111.964 11.63
Property/Plant/Equipment, Total - Gross 357.551 298.599 122.186 19.532
Accumulated Depreciation, Total -82.955 -41.669 -10.222 -7.902
Intangibles, Net 16.867 7.673 2.038 0
Other Long Term Assets, Total 31.964 5.435 18.628 0.227
Total Current Liabilities 71.195 166.936 155.896 4.751
Accounts Payable 7.15 37.208 23.847 1.168
Accrued Expenses 60.117 36.645 9.619 0.566
Notes Payable/Short Term Debt 0 0 0 0
Current Port. of LT Debt/Capital Leases 2.362 2.621 6.683 2.977
Other Current Liabilities, Total 1.566 90.462 115.747 0.04
Total Liabilities 118.086 233.31 241.405 11.795
Total Long Term Debt 0.849 3.271 3.188 4.315
Long Term Debt 0 1.331 3.818
Capital Lease Obligations 0.849 3.271 1.857 0.497
Other Liabilities, Total 46.042 63.103 82.321 2.729
Total Equity 576.494 706.75 74.923 15.566
Redeemable Preferred Stock 0 176.323 73.705
Common Stock 0.001 0.001 0 0
Additional Paid-In Capital 794.567 730.767 9.036 4.945
Retained Earnings (Accumulated Deficit) -218.074 -24.018 -110.436 -63.084
Total Liabilities & Shareholders’ Equity 694.58 940.06 316.328 27.361
Total Common Shares Outstanding 150.406 146.403 143.767 143.767
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total Current Assets 212.075 286.997 371.153 521.872 620.135
Cash and Short Term Investments 128.551 178.201 241.53 304.654 363.124
Cash & Equivalents 128.551 178.201 241.53 304.654 363.124
Total Receivables, Net 1.707 9.799 18.751 24.779 54.008
Accounts Receivable - Trade, Net 1.707 9.799 18.751 24.779 54.008
Total Inventory 68.373 82.006 82.21 133.309 139.047
Prepaid Expenses 9.318 11.617 15.728 44.355 50.436
Other Current Assets, Total 4.126 5.374 12.934 14.775 13.52
Total Assets 523.859 608.561 694.58 825.036 914.075
Property/Plant/Equipment, Total - Net 258.199 268.739 274.596 279.543 276.102
Property/Plant/Equipment, Total - Gross 362.316 362.252 357.551 351.866 337.997
Accumulated Depreciation, Total -104.117 -93.513 -82.955 -72.323 -61.895
Intangibles, Net 21.769 19.774 16.867 16.044 10.936
Other Long Term Assets, Total 31.816 33.051 31.964 7.577 6.902
Total Current Liabilities 57.03 67.458 71.195 175.462 210.031
Accounts Payable 11.21 16.644 7.15 32.521 38.351
Accrued Expenses 43.596 47.912 60.117 55.461 83.499
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 1.756 2.148 2.362 2.581 2.605
Other Current Liabilities, Total 0.468 0.754 1.566 84.899 85.576
Total Liabilities 100.682 112.698 118.086 235.076 273.702
Total Long Term Debt 0 0.417 0.849 1.268 1.99
Long Term Debt
Capital Lease Obligations 0 0.417 0.849 1.268 1.99
Other Liabilities, Total 43.652 44.823 46.042 58.346 61.681
Total Equity 423.177 495.863 576.494 589.96 640.373
Redeemable Preferred Stock
Common Stock 0.002 0.002 0.001 0.001 0.001
Additional Paid-In Capital 819.311 808.133 794.567 776.527 760.637
Retained Earnings (Accumulated Deficit) -396.136 -312.272 -218.074 -186.568 -120.265
Total Liabilities & Shareholders’ Equity 523.859 608.561 694.58 825.036 914.075
Total Common Shares Outstanding 152.662 151.568 150.406 149.178 147.834
  • Annual
  • Quarterly
2022 2021 2020 2019
Net income/Starting Line -194.056 86.418 -47.352 -20.606
Cash From Operating Activities -111.919 -9.449 92.655 -12.996
Cash From Operating Activities 44.942 32.509 6.282 3.653
Non-Cash Items 71.192 120.142 5.646 0.338
Cash Interest Paid 0 0.767 -0.113 0.045
Changes in Working Capital -30.529 -251.986 128.079 3.619
Cash From Investing Activities -63.031 -115.717 -78.148 -2.945
Capital Expenditures -63.031 -115.717 -78.148 -2.945
Cash From Financing Activities -6.43 419.621 100.243 3.61
Financing Cash Flow Items 0.635 -8.128 -3.564 0
Issuance (Retirement) of Stock, Net -4.216 201.968 101.079 0.012
Issuance (Retirement) of Debt, Net -2.849 225.781 2.728 3.598
Net Change in Cash -181.38 294.455 114.75 -12.331
Cash Taxes Paid 3.789 18.106 0.34
Deferred Taxes -3.468 3.468
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -94.198 -194.056 -162.55 -96.247 2.803
Cash From Operating Activities -53.883 -111.919 -60.219 -20.311 31.521
Cash From Operating Activities 12.064 44.942 32.989 21.585 10.606
Non-Cash Items 17.1 71.192 100.503 79.863 18.096
Cash Interest Paid 0 0 0 0.023 0
Changes in Working Capital 11.151 -30.529 -27.683 -23.298 0.016
Cash From Investing Activities -8.318 -63.031 -52.946 -34.68 -14.055
Capital Expenditures -8.318 -63.031 -52.946 -34.68 -14.055
Cash From Financing Activities -1.128 -6.43 -4.557 -4.261 -0.873
Financing Cash Flow Items 0.37 0.635 0.378 0.086 0.273
Issuance (Retirement) of Stock, Net -0.828 -4.216 -2.755 -2.956 -0.45
Issuance (Retirement) of Debt, Net -0.67 -2.849 -2.18 -1.391 -0.696
Net Change in Cash -63.329 -181.38 -117.722 -59.252 16.593
Deferred Taxes -3.468 -3.478 -2.214
Cash Taxes Paid 0 3.789 0

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Cue Health Inc. Company profile

About Cue Health Inc

Cue Health Inc. is a health technology company. The Company has developed a platform, the Cue Integrated Care Platform, with a focus on user experience, convenience, and accuracy. The Cue Integrated Care Platform consists of hardware and software components: Cue Health Monitoring System includes Cue Reader, made up of a portable, durable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand a sample collection wand; Cue Data and Innovation Layer, with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, including its consumer-friendly Cue Health App and its Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, which allow for integrations with third-party applications and sensors. Its product offering is Cue COVID-19 Test. Its COVID-19 test, consist Cue Reader and COVID-19 Test Kit (Cue COVID-19 Cartridge and Cue Wand), is designed to detect SARS-CoV-2, the virus that causes COVID-19.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Cue Health Inc revenues increased from $9.7M to $425.6M. Net income totaled $52.2M vs. loss of $27.8M. Revenues reflect Software segment increase from $4.7M to $223.7M. Net Income reflects Software segment income totaling $87.4M vs. loss of $8.5M. Basic Earnings per Share excluding Extraordinary Items increased from -$0.19 to $0.36.

Industry: Software (NEC)

4980 Carroll Canyon Road
Suite 100
SAN DIEGO
CALIFORNIA 92121
US

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

XRP/USD

0.64 Price
+3.240% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,218.08 Price
+1.050% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.30

BTC/USD

70,659.20 Price
+2.540% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

18,236.90 Price
-0.240% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading